AstraZeneca has announced that its Calquence drug has been approved in the US when used alongside chemoimmunotherapy for ...

Wall Street stocks were in the red at the close of trading on Thursday as Q4 earnings season began to pick up steam.

London equities ended Thursday in positive territory, with investors buoyed by weaker-than-expected UK growth data that ...

Consumer spend in the US slowed a tad at the tail-end of 2024, but sufficed for economists to lift their fourth quarter ...

PetroTal issued its 2025 guidance on Thursday, forecasting significant production growth alongside reduced capital spending.

Antofagasta was in the black as the Chilean miner reiterated its 2025 outlook, despite copper production narrowly missing ...

Wall Street stocks were in the red early on Thursday as Q4 earnings season began to pick up steam. As of 1530 GMT, the Dow ...

Asthma diagnosis and monitoring device specialist Niox Group reported a solid end to its financial year on Thursday, ...

Americans lined up for unemployment benefits at an accelerated pace in the week ended 11 January, according to the Department ...

Morgan Stanley ended 2024 with a robust fourth quarter, reporting a more than doubling of net income on Thursday to $3.7bn, ...

Advanced transport testing, simulation, and measurement specialist AB Dynamics reported solid trading performance for the ...

Analysts at Berenberg raised their target price on reviews website operator Trustpilot from 270.0p to 330.0p on Thursday ...